Faculty Directory

Home > Academics > Faculty Directory

Myung, Jae Kyung, Ph.D.(full-time professor)
Faculty Appointment

Assistant Professor, Department of Cancer Biomedical Science, NCC-GCSP
Area of Expertise

Systems Biology/ Steroid Hormone Receptors/ Small Molecule Anticancer Drug
Contact no
Previous Appointment(s) Held
Post-Doctoral Fellow, British Columbia Cancer Agency
Post-Doctoral Fellow, University of California, Berkeley
Educational Background
Ph.D University of Vienna
M.Eng. Yonsei University
B.S. Kyunghee University
Research Interests (Please place in paragraph form)
Dr. Myung’s research focuses on understanding the molecular mechanisms of steroid hormone receptors and biological active small molecule drugs by the application of a systems biology approach to elucidate complex biological systems in cancer disease.
Integration of highly sophisticated technology-driven “-omics” approaches can provide comprehensive understanding of the underlying molecular and cellular mechanisms and further discover biomarkers, which contributes significant developments in highly promising diagnosis and treatment as well as assessment of prognosis and treatment response in a clinical setting.
International Collaboration
2019 SCI-E The Role of ZNF143 in Breast Cancer Cell Survival Through the NAD(P)H Quinone Dehydrogenase 1-p53-Beclin1 Axis Under Metabolic Stress: CELLS. 8(4):E296~E296 (5.656)

2017 SCI Clinical multi-omics strategies for the effective cancer management: Journal of Proteomics. 188:97~106 (3.914)

2017 SCI Differential proteome expression analysis of androgen-dependent and -independent pathways in LNCap prostate cancer cells: Experimental Cell Research. 359(1):215~225 (3.546)

2017 SCI-E Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer: PLoS One. 12:e0174134~e0174134 ()

2017 SCI-E Identification of calgranulin B interacting proteins and network analysis in gastrointestinal cancer cells: PLoS One. 12(2):e0171232~e0171232 (2.806)

2017 SCI-E Proteins that interact with calgranulin B in the human colon cancer cell line HCT-116: Oncotarget. 8(4):6819~6823 (5.008)

2013 SCI An androgen receptor N-terminal domain antagonist for treatingprostate cancer: Journal of Clinical Investigation. :2948~2960 (12.81)

2012 SCI Large scale phosphoproteome analysis of LNCaP human prostate cancer cells: Mol Biosyst. :2174~2182 ()

2011 SCI-E FUS/TLS is a co-activator of androgen receptor in prostate cancer cells: PLoS One. :e24197~e24197 ()

2010 SCI Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor.: Cancer Cell. :535~546 ()

2009 SCI Developmental brain protein level changes in the C57BL/6J mouse: J Proteome Res. :1207~1219 ()

2008 SCI Mass spectrometrical analysis of the processed metastasis-inducing anterior gradient protein 2 homolog reveals 100% sequence coverage: Amino Acids. :485~494 ()

2006 SCI Use of solution-IEF-fractionation leads to separation of 2673 mouse brain proteins including 255 hydrophobic structures.: J Proteome Res. :1267~1275 ()

2006 SCI Possible dysregulation of chaperon and metabolic proteins in cystic fibrosis bronchial tissue: Proteomics. :3381~3388 ()

2005 SCI Mass spectrometrical analysis of human serine racemase in foetal brain: J Neural Transm. :805~811 ()

2005 SCI Detection of hypothetical proteins in human fetal perireticular nucleus.: J Proteome Res. :2379~2385 ()

2004 SCI Expressional patterns of chaperones in ten human tumor cell lines.: Proteome Sci.. :8~8 ()

2003 SCI Deranged hypothetical proteins Rik protein, Nit protein 2 and mitochondrial inner membrane protein, Mitofilin, in fetal Down syndrome brain: Cell Mol Biol. :739~746 ()

2003 SCI Expressional pattern of chaperones in neuronal, glial, amnion, mesothelial, and bronchial epithelial cell lines.: Mol Genet Metab. :444~450 ()